Brno, Czechia

Miroslav Malecek


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miroslav Malecek: Innovator in Pharmaceutical Composition

Introduction

Miroslav Malecek is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions with antitumor activity. His innovative work has led to the creation of a unique pharmaceutical composition that utilizes carboplatin.

Latest Patents

Miroslav Malecek holds a patent for a pharmaceutical composition with antitumor activity based on carboplatin. This invention involves an aqueous solution of carboplatin with a content ranging from 1 to 20 mg/ml. The composition is designed to contain less than 0.1% by weight of 1,1-cyclobutanedicarboxylic acid (CBDCA) and/or its salt, based on the weight of the carboplatin present, immediately after its preparation.

Career Highlights

Miroslav Malecek is associated with Pliva-Lachema A.S., where he has been instrumental in advancing pharmaceutical research and development. His work has focused on creating effective treatments for cancer, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations

Miroslav has collaborated with notable colleagues, including Vladimír Kysilka and Libuse Zatloukalová. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Miroslav Malecek's contributions to pharmaceutical innovation, particularly in antitumor compositions, highlight his role as a significant inventor in the field. His work continues to impact the development of effective cancer treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…